MD Anderson Presentations at SSO

Pre-course: Surgical clinical trials primer: Designing your study (non-CME)

8 a.m.–12:30 p.m.

Why trials fail: Beyond just sample size
10:45–11:05 a.m.
Faculty: Hop Tran Cao, M.D.

Breast great debate

8:55–9:55 a.m.

Debate #1: When clinical trials answer only one piece of the puzzle: How should multidisciplinary teams implement partial evidence in locoregional breast cancer management — Con
9:08–9:18 a.m.
Faculty: Simona Shaitelman, M.D.

Debate #1: Rebuttal — Con
9:20–9:22 a.m.
Faculty: Simona Shaitelman, M.D.

Debate # 2: Should pCR allow us to omit surgery? — Pro
9:24–9:31 a.m.
Faculty: Helen Johnson, M.D.

Debate # 2: Rebuttal — Pro
9:39–9:40 a.m.
Faculty: Helen Johnson, M.D.

HPB great debate: Histotripsy for liver malignancies: Breakthrough or hype?

8:55–9:55 a.m.
Moderator: Hop Tran Cao, M.D.

2025 American Thyroid Association differentiated thyroid cancer guidelines: What is new? A surgical summary

10:30 a.m.–12 p.m.
Moderator: Sarah Fisher, M.D.

Panel with case discussions to facilitate real-world application of the guidelines
11:17–11:57 a.m.
Faculty: Elizabeth Grubbs, M.D.

Abstract presentations: PSM

1:55–3:25 p.m.
Moderator: Beth Helmink, M.D., Ph.D.

Early-onset colorectal cancer: Epidemiology, genetics, and evolving management (non-CME)

4–5 p.m.

Screening, prevention, and future directions in early-onset colorectal cancer
4:36–4:47 p.m.
Faculty: Nancy You, M.D.

Management across the pancreatic adenocarcinoma continuum: From precursors to metastases

8–9:30 a.m.

Oligometastases: Whether treatment should be expanded to surgery
8:47–9:02 a.m.
Faculty: Matthew Katz, M.D.

Patient-centered rectal cancer care

8–9:30 a.m.
Moderator: Joshua Smith, M.D., Ph.D.

Sequencing — chemotherapy or radiation first for LARC? And why?
8:27–8:39 a.m.
Faculty: Nancy You, M.D.

SSO awards assembly

10:20–10:50 a.m.

Charles M. Balch Distinguished Service Award
10:20–10:30 a.m.
Recipient: Peter Pisters, M.D.

Bridging the gap: Developing APPs from new hire to independent practitioners in surgical oncology (non-CME)

1–2 p.m.
Moderator: Steven Wei, Ed.D.

Expanding impact: APP transition to independent practice: APP role utilization and how to optimize success through APP independent practice clinics
1:25–1:35 p.m.
Faculty: Rae Reynolds, Ph.D.

Great debate: Controversies in the management of gastroesophageal junction (GEJ) cancers

2:35–3:35 p.m.

Debate #2: Surgery Should Not Be Omitted
3:17–3:27 p.m.
Faculty: Brian Badgwell, M.D.

Debate #2: Rebuttal — Surgery should not be omitted
3:30–3:33 p.m.
Faculty: Brian Badgwell, M.D.

ctDNA in GI surgical oncology — game changer or prognostic gimmick?

10:30 a.m.–12 p.m.

Clinical implications of ctDNA in locoregional colorectal cancer
10:35–10:47 a.m.
Faculty: Nancy You, M.D.